Lidocaine

In some countries, this medicine may only be approved for veterinary use.

In the US, Lidocaine (hydrocortisone/lidocaine topical) is a member of the following drug classes: group I antiarrhythmics, local injectable anesthetics and is used to treat Anesthesia, Arrhythmia, Burning Mouth Syndrome, Costochondritis, Ventricular Fibrillation and Ventricular Tachycardia.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01BB01,C05AD01,D04AB01,N01BB02,R02AD02,S01HA07,S02DA01

CAS registry number (Chemical Abstracts Service)

0000137-58-6

Chemical Formula

C14-H22-N2-O

Molecular Weight

234

Therapeutic Categories

Anesthetic, local

Antiarrhythmic agent, class Ib

Chemical Names

2-Diethylamino-N-(2,6-dimethylphenyl)acetamid (IUPAC)

2-Diethylamino-2',6'-acetoxylidide (WHO)

Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-

Foreign Names

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web3)